Uang X, Huang F, Shao W, Li S, Chen Y, Cai
Uang X, Huang F, Shao W, Li S, Chen Y, Cai J: BMP2 promotes migration and invasion of breast cancer cells by way of cytoskeletal reorganization and adhesion reduce: an AFM investigation. Appl Microbiol Biotechnol 2012, ninety three:1715? 1723. Raida M, Clement JH, Leek RD, Ameri K, Bicknell R, Niederwieser D, Harris AL: Bone morphogenetic protein two (BMP-2) and induction of tumor angiogenesis. J Most cancers Res Clin Oncol 2005, 131:741? 750. Clement JH, Raida M, Sanger J, Bicknell R, Liu J, Naumann A, Geyer A, Waldau A, Hortschansky P, Schmidt A, Hoffken K, Wolft S, Harris AL: Bone morphogenetic protein two (BMP-2) induces in vitro PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28552076 invasion and in vivo hormone impartial expansion of breast carcinoma cells. Int J Oncol 2005, 27:401? 407. Sartor CI, Zhou H, Kozlowska E, Guttridge K, Kawata E, Caskey L, Harrelson J, Hynes N, Ethier S, Calvo B, Earp HS III: Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells. Mol Cell Biol 2001, 21:4265? 4275. Naresh A, Prolonged W, Vidal GA, Wimley WC, Marrero L, Sartor CI, Tovey S, Cooke TG, Bartlett JM, Jones FE: The ERBB4/HER4 intracellular domain 4ICD is often a BH3-only protein endorsing apoptosis of breast most cancers cells. Cancer Res 2006, sixty six:6412? 6420. Spike BT, Engle DD, Lin JC, Cheung SK, La J, Wahl GM: A mammary stem cell inhabitants recognized and characterized in late embryogenesisCohen et al. Breast Most cancers ResearchPage sixteen of65.sixty six.67.68.sixty nine.70. 71. seventy two.seventy three.seventy four.75.76.77. seventy eight.79. eighty.eighty one.reveals similarities to human breast most cancers. Mobile Stem Mobile 2012, ten:183? 197. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, Hur MH, Diebel ME, Monville F, Dutcher J, Brown M, Viens P, Xerri L, Bertucci F, Stassi G, Dontu G, Birnbaum D, (Z)-Pitavastatin calcium Wicha MS: Breast cancer cell traces consist of useful cancer stem cells with metastatic capacity as well as a distinctive molecular signature. Cancer Res. 2009, sixty nine:1302? 1313. Pei XH, Bai F, Smith MD, Usary J, Lover C, Pai SY, Ho IC, Perou CM, Xiong Y: CDK inhibitor p18(INK4c) is actually a downstream focus on of GATA3 and restrains mammary luminal progenitor mobile proliferation and tumorigenesis. Most cancers Mobile 2009, fifteen:389? 401. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N: The cBio cancer genomics portal: an open up system for discovering multidimensional most cancers genomics info. Most cancers Discov 2012, two:401? 404. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N: Integrative analysis of elaborate most cancers genomics and clinical profiles employing the cBioPortal. Sci Sign 2013, six:l1. Ho IC, Tai TS, Pai SY: GATA3 as well as T-cell lineage: critical functions ahead of and just after T-helper-2-cell differentiation. Nat Rev Immunol 2009, nine:a hundred twenty five? one hundred thirty five. Vargo-Gogola T, Rosen JM: Modelling breast most cancers: 1 dimension isn't going to match all. Nat Rev Most cancers 2007, seven:659? 672. Beelen K, Zwart W, Linn SC: Can predictive biomarkers in breast most cancers guide adjuvant endocrine treatment? Nat Rev Clin Oncol 2012, 9:529? 541. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28119436 Wees J, Lindeman GJ, Visvader JE: Gata-3 is undoubtedly an vital regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Mobile Biol 2007, 9:201? 209. Ciocca V, Daskalakis C, Ciocca RM, Ruiz-Orrico A, Palazzo JP: The importance of GATA3 expression in breast cancer: a 10-year follo.
Forum Role: Spectator
Topics Started: 0
Replies Created: 0